The last IPO of the year 2025 will open on 31 December. Modern Diagnostic and Research Center is launching an issue in the SME segment. The minimum amount for investment in this will be around Rs 2.88 lakh.
IPO News: The year 2025 has now reached its last phase and with this the last IPO of the year is about to come in the primary market also. If you are planning to invest in the stock market through a new issue, then this news is very important for you. There may not be any new IPO in the mainboard segment next week, but an important issue is going to open for investors in the SME segment.
Limited movement in primary market
There will not be much activity in the primary market in the coming week. The mainboard segment will remain completely quiet and no new IPO will be launched. However, at the beginning of the week, a mainboard company named Gujarat Kidney is going to be listed, on which investors will keep an eye.
Movement continues in SME segment
While there will be silence in the mainboard, there will be movement in the SME segment. Only one new IPO will be launched in this segment, but the listing of many companies will make the end of the year busy. Shares of SME companies like EPW India, Dachepalli Publishers, Shyam Dhani Industries and Sundarex Oil Company will be listed in the market on Tuesday, December 30.
Last IPO of the year 2025
Modern Diagnostic and Research Center, a company related to the diagnostic sector, is bringing its last IPO of the year 2025. This IPO will open for subscription on Wednesday, December 31, 2025. This issue of the company will close on Friday, January 2, 2026. In such a situation, investors will have limited time to apply.
Size and objective of IPO
Modern Diagnostic and Research Center will bring a fresh issue of total 4.1 million equity shares through this IPO. Through this the company is planning to raise around ₹36.89 crore. The funds raised will be used to meet business expansion, working capital and general corporate needs.
Complete information about price band
The company has fixed the price band of shares for its IPO at ₹85 to ₹90 per share. This issue falls in the SME category, hence the lot size has been kept large. One lot will consist of 1,600 shares.
How much amount is required for investment
If an investor wants to apply in this IPO, he will have to bid for at least one lot. According to the upper price band, the minimum investment amount will be around ₹ 2,88,000. This is the reason why this IPO is considered more suitable especially for high net worth investors and experienced investors.
Allotment and listing date
The allotment of shares is likely to be finalized on Monday, January 5, 2026, after the closing of the IPO. Investors who will be allotted shares can have their equity shares credited to their demat accounts by Tuesday, January 6, 2026. After this, the shares of the company will be listed on the BSE SME platform on Wednesday, January 7, 2026.
Current status of GMP
Investors are always curious about Gray Market Premium i.e. GMP. According to InvestorGain, at present the GMP of Modern Diagnostic and Research Center IPO is going on zero. This means that right now no significant premium is being seen regarding this IPO in the gray market. However, it is also important to note that GMPs are subject to change leading up to listing.
Why is GMP important?
GMP estimates the range in which the stock may open on the day of listing. But this is not an official signal. It has been seen many times that despite low GMP, the listing of shares has remained strong, while even after high GMP, the shares have been listed under pressure.
Comments are closed.